BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17828652)

  • 41. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depressive symptoms in youth heads of household in Rwanda: correlates and implications for intervention.
    Boris NW; Brown LA; Thurman TR; Rice JC; Snider LM; Ntaganira J; Nyirazinyoye LN
    Arch Pediatr Adolesc Med; 2008 Sep; 162(9):836-43. PubMed ID: 18762600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substance abuse and psychosocial impairments among clients with schizophrenia.
    Schwartz RC; Hilscher RL; Hayhow P
    Am J Orthopsychiatry; 2007 Oct; 77(4):610-5. PubMed ID: 18194040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Panic symptoms in schizophrenia: comorbidity and clinical correlates.
    Ulas H; Alptekin K; Akdede BB; Tumuklu M; Akvardar Y; Kitis A; Polat S
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):678-80. PubMed ID: 18081631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and association of somatic symptoms in patients with Major Depressive Disorder.
    Vaccarino AL; Sills TL; Evans KR; Kalali AH
    J Affect Disord; 2008 Oct; 110(3):270-6. PubMed ID: 18280580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence and correlates of trauma-related symptoms in schizophrenia spectrum disorder.
    Lysaker PH; Larocco VA
    Compr Psychiatry; 2008; 49(4):330-4. PubMed ID: 18555051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anxiety and depression symptoms in patients with diabetes.
    Collins MM; Corcoran P; Perry IJ
    Diabet Med; 2009 Feb; 26(2):153-61. PubMed ID: 19236618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder.
    Yen CF; Chen CC; Cheng CP; Yen CN; Lin HC; Ko CH; Yen JY; Chen CS
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):685-90. PubMed ID: 19068005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The association between disability and residual symptoms in depressive patients: a 3-month follow-up].
    Ozyüksel B; Uluğ B
    Turk Psikiyatri Derg; 2007; 18(4):323-32. PubMed ID: 18066723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression.
    Zisook S; Nyer M; Kasckow J; Golshan S; Lehman D; Montross L
    Schizophr Res; 2006 Sep; 86(1-3):226-33. PubMed ID: 16750346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occult depressive symptoms in adolescent emergency department patients.
    Biros MH; Hick K; Cen YY; Mann J; Gaetz A; Hansen R; Schiming R
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):769-73. PubMed ID: 18678810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anxiety disorders in adults treated by hemodialysis: a single-center study.
    Cukor D; Coplan J; Brown C; Friedman S; Newville H; Safier M; Spielman LA; Peterson RA; Kimmel PL
    Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basic symptoms in early psychotic and depressive disorders.
    Schultze-Lutter F; Ruhrmann S; Picker H; von Reventlow HG; Brockhaus-Dumke A; Klosterkötter J
    Br J Psychiatry Suppl; 2007 Dec; 51():s31-7. PubMed ID: 18055935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.
    Sumnall HR; Cole JC
    J Psychopharmacol; 2005 Jan; 19(1):84-92. PubMed ID: 15671133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
    Marrie RA; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Mult Scler; 2009 Mar; 15(3):385-92. PubMed ID: 19153176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.